Skip to content
PHARM | TCAs Amitriptyline episode artwork

Oct 28, 2025 37 min

PHARM | TCAs Amitriptyline

from STAT Stitch Deep Dive Podcast Beyond The Bedside

💊 PHARM STUDY GUIDE: AMITRIPTYLINE (Elavil) Class: Tricyclic Antidepressant (TCA) 🧠 MOA (80/20): Blocks neuronal reuptake of serotonin & norepinephrine; also anticholinergic, antihistamine, and sodium-channel effects → efficacy + side-effect burden. NCBI 📋 Indications (what you’ll actually see): Major depressive disorder Off-label, low dose: neuropathic pain, migraine prevention, insomnia (sedating). ⚠️ Red-Flag Side Effects (Prioritize 🚨): Cardiac toxicity – QT prolongation, conduction block, ventricular arrhythmias; overdose can be fatal. Monitor ECG/electrolytes in risk pts. Serotonin syndrome (with MAOIs/serotonergics): fever, agitation, hyperreflexia, diarrhea, tremor, clonus. Stop drug; supportive care; consider cyproheptadine. Anticholinergic crisis – delirium, urinary retention, ileus, hyperthermia (elderly esp.). Orthostatic hypotension & falls (α1-blockade). Suicidality boxed warning in children, adolescents, young adults—highest risk at start & dose changes. 🩺 Nursing Interventions & Monitoring: Baseline & periodic BP/HR, ECG if cardiac risk, electrolyte check (K/Mg) if QT risk. Screen for suicidal ideation early and with any dose change. Watch for anticholinergic effects (bowel regimen, fluids), falls, urinary retention. Assess for drug interactions (see below) and serotonin syndrome. 🚫 Contraindications & Dangerous Combos: MAOIs: contraindicated; 14-day washout (risk of hyperpyrexia/convulsions/SS). Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) ↑ TCA levels → toxicity; avoid or adjust/monitor closely. Additive QT-prolonging meds (amiodarone, macrolides, antipsychotics) → arrhythmia risk. Potentiation with other anticholinergics/CNS depressants (falls, delirium). 🎯 Top 5 High-Yield Takeaways: Powerful but not first-line due to side effects/toxicity—reserve for refractory depression or low-dose pain/migraine. Cardiac safety first: screen QT risks, consider baseline ECG. Night dosing, slow titration, and taper to discontinue. Avoid MAOIs; beware CYP2D6 inhibitors (e.g., fluoxetine). Monitor suicidality, anticholinergic burden, falls, and serotonin syndrome. 🧩 80/20 Summary: Think TCA = reuptake block + anticholinergic + cardiac risk. Safe use = low & slow, night dose, ECG when needed, interaction check, taper, monitor mood & SS.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

PHARM | TCAs Amitriptyline

0:00 37:35

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of STAT Stitch Deep Dive Podcast Beyond The Bedside?

This episode is 37 minutes long.

When was this STAT Stitch Deep Dive Podcast Beyond The Bedside episode published?

This episode was published on October 28, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this STAT Stitch Deep Dive Podcast Beyond The Bedside episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.